glp 1 agonist diabetes GLP-1 Receptor Agonists as Treatments for Type 2 The role of GLP1 receptor
Description
The recent launch of the Wegovy pill and a pipeline full of next-generation weight loss drugs are already having major consequences on apparel, aesthetics and other attendant industries
GLP-1 has shown the ability to promote angiogenesis by increasing vessel formation and perfusion [12, 13]
Incretin agonist clinical trials most frequently reveal nausea as an adverse effect
doi: 10.3389/fendo.2022.1033479 Received 31 August 2022 Accepted 27 October 2022 Published 17 November 2022 Volume 13 - 2022 Edited by Jianbo Zhou, Beijing Tongren Hospital, Capital Medical University, China Reviewed by Finbarr P
British journal of pharmacology
[DOI] [PubMed] [Google Scholar] 130.Hansen HH, et al
